Displaying posts published in

September 2016

Clinton’s Stealthy Single-Payer Gambit The ‘public option’ could be implemented around the country—without congressional approval. By Scott Gottlieb

Dr. Gottlieb is a physician and resident fellow at the American Enterprise Institute. He consults with and invests in health-care companies.
It looks like 2017 will be ObamaCare’s worst year yet. The three major insurers, along with many smaller plans, are largely exiting the health-insurance exchanges, leaving more than half of U.S. counties with only one or two health-plan choices, according to the Kaiser Family Foundation. Nearly 36% of ObamaCare regions may have only one participating insurance carrier offering plans for 2017, according to health-care analytics firm Avalere Health. Data from analysts at Barclays and Credit Suisse project that health-insurance premiums are expected to rise at least 24% in 2017.

To rescue President Obama’s health-care law, Hillary Clinton has proposed resurrecting the “public option.” This failed idea—a government-run health-care plan to compete with private insurers—can’t save ObamaCare. But introducing it across the country would move the U.S. much closer to the single-payer system progressives have always longed for.

Mrs. Clinton positions the states as vehicles for the public option, and this isn’t because she discovered a late-in-life appreciation for federalism. Section 1332 of the Affordable Care Act, a little-known provision, allows states to renounce almost all of ObamaCare’s dictates. That includes the law’s politically sacred rules governing the medical benefits consumers are promised and the subsidy structure that helps pay for them. States only need to develop alternative schemes that can achieve the same level of similarly priced coverage that they would attain under ordinary ObamaCare.

In 2011 Vermont tried to use this waiver process to introduce a public option, only to abandon it three years later when it became clear that the scheme would yield skyrocketing taxes on small businesses. Minnesota, Maine and Rhode Island are proposing variations of this scheme for implementation after 2017. Maine’s proposed law boasts of its intent to use “federal funds to the maximum extent allowable under federal law.” Colorado is using the 1332 waiver to pursue its own single payer through an initiative on the ballot this November.

The real juice is the funding. To pay for these schemes, the 1332 waivers let states pocket the aggregate subsidies—including premium tax credits, cost-sharing subsidies, and small-business tax credits—that they would otherwise receive under ObamaCare. This federal slush fund could give states billions of dollars annually to subsidize their own publicly run health plan.

The process gives the executive branch broad authority to coax or even coerce states to pursue the creation of these public options—without congressional consent. ObamaCare requires that any new scheme be “deficit neutral” relative to the cost of the law. So long as the new public option won’t add to ObamaCare’s costs, the state can use the law’s subsidies to pay for government-run plans. The waivers give states ample ability to use savings claimed by setting price controls on medical care as a way to meet the budget goals.

Federal regulators would approve new public options based on White House budget office estimates of the program’s cost and impact on a state’s existing insurance market. The Obama administration has abused this broad discretion before: Officials manipulated “budget neutrality” by allowing states like Arkansas to expand their Medicaid programs under ObamaCare. CONTINUE AT SITE

Israel and the F-35 By Stephen Bryen and Rachel Ehrenfeld

Like it or not, the increasingly aggressive Iranian posture toward Israel suggests that sooner or later their conflict will develop into a ground and air war. Actions by Iran and its surrogates in the area of the Golan Heights already caused some Israeli land and retaliatory air moves, and more provocations could set off broader fighting. Israel has little choice but to deter the Iranian and Syria armies, and Hezbollah, from creating a security nightmare.

Iran has around 265 front line combat fighter aircraft. These consist of American F-14’s, F-4’s, F-5’s and 30 or more Hesa Saegeh locally made aircraft based on the F-5; Russian MIG 29’s; French Mirage F-1s, and Chinese F-7 Chengdu interceptors. The F-7s and F-5s are not a significant factor of any kind today. The F-14s and F-4s are old, but very capable, as are the Mirage and MiG planes. The Iranian F-4s have been upgraded and have new, modern radars and avionics from China. The F-4s also have the new Qader cruise missile which may also be usable on the other planes. The Hesa Saegeh F-5 knock off has engines that could have been smuggled into Iran from outside, no one is sure.

Of all these planes the most lethal is the F-14 because it carries Phoenix missiles. The Phoenix missile was the first true beyond visual range air to air missile with a range exceeding 100 miles. Such missiles were delivered to Iran under the Shah. But to assume they are not operational today would be a mistake because, in all likelihood, the Russians and Chinese have had their hands all over them. Can the Israelis knock such an improved Phoenix out? Possibly, if they use jamming. A better strategy would be to destroy the F-14s before they can do any damage. But this would depend on the quality of Iran’s air defenses, which have been improved lately by S-300 batteries that were delivered by Russia, and whether the Iranians can field an aircraft that can compete with Israel’s F-15s and F-16s.

Can the Israelis knock such an improved Phoenix out? Possibly, if they use jamming. A better strategy would be to destroy the F-14s before they can do any damage. But this would depend on the quality of Iran’s air defenses, which have been improved lately by S-300 batteries that were delivered by Russia, and whether the Iranians can field an aircraft that can compete with Israel’s F-15s and F-16s.

Furthermore, the possibility of a Russian sale of an advanced 4th generation plus fighter, like the Su-35 to Iran, could introduce a major problem for Israel, a problem that would not be solved by the F-35, which has such serious limitations and needs so many fixes that there is doubt it could be ever ready for combat. Because the F-35 cannot dogfight, the Su-35 has the key advantage especially in the role of territorial defense.